Clinical significance of heat shock protein-70 expression in bladder cancer

By Syrigos K.N.   Harrington K.J.   Karayiannakis A.J.   Sekara E.   Chatziyianni E.   Syrigou E.I.   Waxman J.  

Urology, Vol. 61, Iss. 3, 2003-03 ,pp. : 677-680

Elsevier

Access to resources Recommend Favorite

Integrin v and coxsackie adenovirus receptor expression in clinical bladder cancer

By Sachs M.D.   Rauen K.A.   Ramamurthy M.   Dodson J.L.   De Marzo A.M.   Putzi M.J.   Schoenberg M.P.   Rodriguez R.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 531-536

Elsevier

Access to resources Recommend Favorite

Loss of maspin expression in prostate cancer induced by a P53- and HER-2- pathway/overexpression profiling by whole-mount derived tissue microarrays

By Merseburger A.   Kuczyk M.   David M.   Moul J.   Sesterhenn I.   Jonas U.   Mostofi F.   Srivaslava S.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 61-61

Elsevier

Access to resources Recommend Favorite

E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder

By Shariat S.F.   Pahlavan S.   Baseman A.G.   Brown R.M.   Green A.E.   Wheeler T.M.   Lerner S.P.  

Urology, Vol. 57, Iss. 1, 2001-01 ,pp. : 60-65

Elsevier

Access to resources Recommend Favorite

Low IL-1 Expression in Bladder Cancer Tissue and Survival

By Seddighzadeh M.   Larsson P.   Ulfgren A.-C.   Onelov E.   Berggren P.   Tribukait B.   Torstensson A.   Norming U.   Wijkstrom H.   Linder S.   Steineck G.  

European Urology, Vol. 43, Iss. 4, 2003-04 ,pp. : 362-368

Elsevier

Access to resources Recommend Favorite